miRNAs and COVID-19 Therapy Review

Maged Naser, Mohamed M. Naser, Lamia H. Shehata

Abstract


These days, the extreme intense respiratory condition Coronavirus 2 (SARS-CoV-2) disease is recognised on the grounds that the primary cause behind mortality in people. SARS-CoV-2 is transmitted through human-to-human contact and is a symptomless in many patients. furthermore, to approved vaccines against SARS-CoV-2 infection, miRNAs may additionally be promising decisions against the current new virus. miRNAs are small and noncoding RNAs 18–25 nucleotides in length that focus on the mRNAs to degrade them or block their interpretation miRNAs go about as an observer in cells.

This review in regards to evaluated the writing on the potential role of cellular miRNAs inside the SARS-CoV-2-have collaboration as a therapeutic option in COVID-19 patients.


Keywords


coronavirus, COVID-19, miRNA, SARS-CoV-2

Full Text:

PDF

References


- Chang, Le, Ying Yan, and Lunan Wang. "Coronavirus disease 2019: coronaviruses and blood safety." Transfusion medicine reviews 34.2 (2020): 75-80.

- Ren, Li-Li, et al. "Identification of a novel coronavirus causing severe pneumonia in human: a descriptive study." Chinese medical journal 133.9 (2020): 1015.

- Huang, Chaolin, et al. "Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China." The lancet 395.10223 (2020): 497-506.

- Peeri, Noah C., et al. "The SARS, MERS and novel coronavirus (COVID-19) epidemics, the newest and biggest global health threats: what lessons have we learned?" International journal of epidemiology 49.3 (2020): 717-726.

- Rothan, Hussin A., and Siddappa N. Byrareddy. "The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak." Journal of autoimmunity 109 (2020): 102433.

- Bogoch, Isaac I., et al. "Pneumonia of unknown aetiology in Wuhan, China: potential for international spread via commercial air travel." Journal of travel medicine 27.2 (2020): taaa008.

- Lu, Hongzhou, Charles W. Stratton, and Yi‐Wei Tang. "Outbreak of pneumonia of unknown aetiology in Wuhan, China: The mystery and the miracle." Journal of medical virology 92.4 (2020): 401.

- Shu, Yuelong, and John McCauley. "GISAID: Global initiative on sharing all influenza data–from vision to reality." Euro surveillance 22.13 (2017): 30494.

- Pollock, David D., et al. "Viral CpG deficiency provides no evidence that dogs were intermediate hosts for SARS-CoV-2." Molecular biology and evolution 37.9 (2020): 2706-2710.

- Tyrrell, D. A. J., and M. L. Bynoe. "Cultivation of viruses from a high proportion of patients with colds." Lancet (1966): 76-7.

- Hasan, Md Mahmudul, et al. "A computational approach for predicting role of human microRNAs in MERS-CoV genome." Advances in bioinformatics 2014 (2014).

- Giovanetti, Marta, et al. "The first two cases of 2019‐nCoV in Italy: Where they come from?" Journal of medical virology 92.5 (2020): 518-521.

- Paraskevis, Dimitrios, et al. "Full-genome evolutionary analysis of the novel corona virus (2019-nCoV) rejects the hypothesis of emergence as a result of a recent recombination event." Infection, Genetics and Evolution 79 (2020): 104212.

- Banerjee, Arinjay, et al. "Bats and coronaviruses." Viruses 11.1 (2019): 41.

- Li, Wendong, et al. "Bats are natural reservoirs of SARS-like coronaviruses." Science 310.5748 (2005): 676-679.

- Hampton, Tracy. "Bats may be SARS reservoir." Jama 294.18 (2005): 2291-2291.

- Li, Qun, et al. "Early transmission dynamics in Wuhan, China, of novel coronavirus–infected pneumonia." New England journal of medicine (2020).

- Carlos, W. Graham, et al. "Novel Wuhan (2019-nCoV) Coronavirus." Am J Respir Crit Care Med (2020): P7-P8.

- Wu, Peng, et al. "Real-time tentative assessment of the epidemiological characteristics of novel coronavirus infections in Wuhan, China, as at 22 January 2020." Euro surveillance 25.3 (2020): 2000044.

- Wan, Yushun, et al. "Receptor recognition by the novel coronavirus from Wuhan: an analysis based on decade-long structural studies of SARS coronavirus." Journal of virology 94.7 (2020): e00127-20.

- Jaimes, Javier A., et al. "A tale of two viruses: the distinct spike glycoproteins of feline coronaviruses." Viruses 12.1 (2020): 83.

- Matsuyama, Shutoku, et al. "Enhanced isolation of SARS-CoV-2 by TMPRSS2-expressing cells." Proceedings of the National Academy of Sciences 117.13 (2020): 7001-7003.

- Rothe, Camilla, et al. "Transmission of 2019-nCoV infection from an asymptomatic contact in Germany." New England journal of medicine 382.10 (2020): 970-971.

- Nassar, MS1, et al. "Middle East Respiratory Syndrome Coronavirus (MERS-CoV) infection: epidemiology, pathogenesis and clinical characteristics." Eur Rev Med Pharmacol Sci 22.15 (2018): 4956-4961.

- Malave, Adriel, and Elamin M. Elamin. "Severe acute respiratory syndrome (SARS): lessons for future pandemics." AMA Journal of Ethics 12.9 (2010): 719-725.

- Lin, Min-Han, et al. "Structural and functional characterization of MERS coronavirus papain-like protease." Journal of biomedical science 21.1 (2014): 1-8.

- Azhar, Esam I., et al. "Evidence for camel-to-human transmission of MERS coronavirus." New England Journal of Medicine 370.26 (2014): 2499-2505.

- van Doremalen, Neeltje, et al. "Host species restriction of Middle East respiratory syndrome coronavirus through its receptor, dipeptidyl peptidase 4." Journal of virology 88.16 (2014): 9220-9232.

- Ambros, Victor. "The functions of animal microRNAs." Nature 431.7006 (2004): 350-355.

- Bartel, David P. "MicroRNAs: genomics, biogenesis, mechanism, and function." cell 116.2 (2004): 281-297.

- Esquela-Kerscher, Aurora, and Frank J. Slack. "Oncomirs—microRNAs with a role in cancer." Nature reviews cancer 6.4 (2006): 259-269.

- Serban, Marinela, et al. "Spontaneous echo contrast of unexpected aetiology." European Journal of Echocardiography 7.3 (2006): 257-259.

- Miao, Chenggui, et al. "MicroRNAs in type 1 diabetes: new research progress and potential directions." Biochemistry and Cell Biology 96.5 (2018): 498-506.

- Perkins, Diana O., et al. "microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder." Genome biology 8.2 (2007): 1-11.

- Sonkoly, Enikö, et al. "MicroRNAs: novel regulators involved in the pathogenesis of psoriasis?" PloS one 2.7 (2007): e610.

- Latronico, Michael VG, Daniele Catalucci, and Gianluigi Condorelli. "Emerging role of microRNAs in cardiovascular biology." Circulation research 101.12 (2007): 1225-1236.

- Janssen, Harry LA, et al. "Treatment of HCV infection by targeting microRNA." New England Journal of Medicine 368.18 (2013): 1685-1694.

- Li, Yongsheng, et al. "Comprehensive analysis of the functional microRNA–mRNA regulatory network identifies miRNA signatures associated with glioma malignant progression." Nucleic acids research 41.22 (2013): e203-e203.

- Cui, Feng-Mei, et al. "Radon-induced alterations in micro-RNA expression profiles in transformed BEAS2B cells." Journal of Toxicology and Environmental Health, Part A 76.2 (2013): 107-119.

- Montag, Judith, et al. "Upregulation of miRNA hsa-miR-342-3p in experimental and idiopathic prion disease." Molecular neurodegeneration 4.1 (2009): 1-7.

- Seo, G. J., et al. "Evolutionarily conserved function of a viral microRNA." Journal of virology 82.20 (2008): 9823-9828.

- Melar-New, Marta, and Laimonis A. Laimins. "Human papillomaviruses modulate expression of microRNA 203 upon epithelial differentiation to control levels of p63 proteins." Journal of virology 84.10 (2010): 5212-5221.

- Gupta, A., et al. "Anti-apoptotic function of a microRNA encoded by the HSV-1 latency-associated transcript." Nature 442.7098 (2006): 82-85.

- Ura, Shunsuke, et al. "Differential microRNA expression between hepatitis B and hepatitis C leading disease progression to hepatocellular carcinoma." Hepatology 49.4 (2009): 1098-1112.

- Omoto, Shinya, and Yoichi R. Fujii. "Regulation of human immunodeficiency virus 1 transcription by nef microRNA." Journal of General Virology 86.3 (2005): 751-755.

- Dunn, Walter, et al. "Human cytomegalovirus expresses novel microRNAs during productive viral infection." Cellular microbiology 7.11 (2005): 1684-1695.

- Sullivan, Christopher S., et al. "SV40-encoded microRNAs regulate viral gene expression and reduce susceptibility to cytotoxic T cells." Nature 435.7042 (2005): 682-686.

- Seo, Gil Ju, Chun Jung Chen, and Christopher S. Sullivan. "Merkel cell polyomavirus encodes a microRNA with the ability to auto regulate viral gene expression." Virology 383.2 (2009): 183-187.

- Qin, Zhao-ling, et al. "Silencing of SARS-CoV spike gene by small interfering RNA in HEK 293T cells." Biochemical and biophysical research communications 324.4 (2004): 1186-1193.

- Rebolledo-Mendez, Jovan, et al. "Cross-kingdom sequence similarities between human micro-RNAs and plant viruses." Communicative & integrative biology 6.5 (2013): e24951.

- Vaschetto, Luis María. "A putative miRNA in the spike gene of SARS-CoV-2 has perfect sequence identity to both the forward and reverse complementary strands of hsa-mir-8055 involved in T-cell response to antigen." (2020).

- Sardar, Rahila, et al. "Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host-virus interaction and pathogenesis." BioRxiv (2020).

- Fang, Lei, George Karakiulakis, and Michael Roth. "Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?" The lancet respiratory medicine 8.4 (2020): e21.

- Chen, Lai-Jiang, et al. "The ACE2/apelin signalling, microRNAs, and hypertension." International journal of hypertension 2015 (2015).

- Bartel, David P. "Metazoan micrornas." Cell 173.1 (2018): 20-51.

- Krol, Jacek, Inga Loedige, and Witold Filipowicz. "The widespread regulation of microRNA biogenesis, function and decay." Nature Reviews Genetics 11.9 (2010): 597-610.

- Zhdanov, Vladimir P. "Intracellular miRNA or siRNA delivery and function." BioSystems 171 (2018): 20-25.

- Rakhmetullina, Aizhan, et al. "The miRNA complexes against coronaviruses COVID-19, SARS-CoV, and MERS-CoV." (2020).

- Demirci, Müşerref Duygu Saçar, and Aysun Adan. "Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection." PeerJ 8 (2020): e9369.

- Zhang, Sen, et al. "Up-regulation of microRNA-203 in influenza A virus infection inhibits viral replication by targeting DR1." Scientific reports 8.1 (2018): 1-15.

- Komatsu, Kiyoshi, et al. "Human homologue of S. pombe Rad9 interacts with BCL-2/BCL-x L and promotes apoptosis." Nature cell biology 2.1 (2000): 1-6.

- Liu, Zhi, et al. "Implications of the virus-encoded miRNA and host miRNA in the pathogenicity of SARS-CoV-2." arXiv preprint arXiv:2004.04874 (2020).

- Balmeh, Negar, et al. "Predicted therapeutic targets for COVID-19 disease by inhibiting SARS-CoV-2 and its related receptors." Informatics in medicine unlocked 20 (2020): 100407.

- Fani, Mona, et al. "The role of miRNAs in COVID-19 disease." Future Virology 16.4 (2021): 301-306.

- Ivashchenko, Anatoliy Timofeevich, et al. "How miRNAs can protect humans from coronaviruses COVID-19, SARS-CoV, and MERS-CoV." BIOINFORMATICS OF GENOME REGULATION AND STRUCTURE/SYSTEMS BIOLOGY (BGRS/SB-2020). 2020.

- Khan, Md, et al. "Epigenetic regulator miRNA pattern differences among SARS-CoV, SARS-CoV-2, and SARS-CoV-2 world-wide isolates delineated the mystery behind the epic pathogenicity and distinct clinical characteristics of pandemic COVID-19." Frontiers in genetics 11 (2020): 765.

- Nersisyan, Stepan, et al. "Potential role of cellular miRNAs in coronavirus-host interplay." PeerJ 8 (2020): e9994.

- Chan, Agnes P., Yongwook Choi, and Nicholas J. Schork. "Conserved genomic terminals of SARS-CoV-2 as coevolving functional elements and potential therapeutic targets." MSphere 5.6 (2020): e00754-20.

- Arisan, Elif Damla, et al. "The prediction of miRNAs in SARS-CoV-2 genomes: hsa-miR databases identify 7 key miRs linked to host responses and virus pathogenicity-related KEGG pathways significant for comorbidities." Viruses 12.6 (2020): 614.

- Demirci, Müşerref Duygu Saçar, and Aysun Adan. "Computational analysis of microRNA-mediated interactions in SARS-CoV-2 infection." PeerJ 8 (2020): e9369.

- Sardar, Rahila, et al. "Comparative analyses of SAR-CoV2 genomes from different geographical locations and other coronavirus family genomes reveals unique features potentially consequential to host-virus interaction and pathogenesis." BioRxiv (2020).

- Hosseini Rad SM, Ali, and Alexander D. McLellan. "Implications of SARS-CoV-2 mutations for genomic RNA structure and host microRNA targeting." International journal of molecular sciences 21.13 (2020): 4807.

- Liu, Zhi, et al. "Implications of the virus-encoded miRNA and host miRNA in the pathogenicity of SARS-CoV-2." arXiv preprint arXiv:2004.04874 (2020).

- Chauhan, Neeraj, et al. "COVID-19: Fighting the invisible enemy with microRNAs." Expert Review of Anti-Infective Therapy 19.2 (2021): 137-145.

- Widiasta, Ahmedz, et al. "Potential role of ACE2-related microRNAs in COVID-19-associated nephropathy." Non-coding RNA research 5.4 (2020): 153-166.

- Arora, Shweta, et al. "Unravelling host-pathogen interactions: ceRNA network in SARS-CoV-2 infection (COVID-19)." Gene 762 (2020): 145057.

- Liu, Zhi, et al. "Implications of the virus-encoded miRNA and host miRNA in the pathogenicity of SARS-CoV-2." arXiv preprint arXiv:2004.04874 (2020).

- Mishra, Paras K., Ritesh Tandon, and Siddappa N. Byrareddy. "Diabetes and COVID-19 risk: a miRNA perspective." American Journal of Physiology-Heart and Circulatory Physiology 319.3 (2020): H604-H609.

- Fulzele, Sadanand, et al. "COVID-19 virulence in aged patients might be impacted by the host cellular microRNAs abundance/profile." Aging and disease 11.3 (2020): 509.

- Guterres, Alexandro, et al. "What is the potential function of microRNAs as biomarkers and therapeutic targets in COVID-19?" Infection, genetics and evolution 85 (2020): 104417.

- Chow, Jonathan Tak-Sum, and Leonardo Salmena. "Prediction and analysis of SARS-CoV-2-targeting MicroRNA in human lung epithelium." Genes 11.9 (2020): 1002.

- Demongeot, Jacques, and Hervé Seligmann. "SARS-CoV-2 and miRNA-like inhibition power." Medical Hypotheses 144 (2020): 110245.

- Nepotchatykh, Evguenia, et al. "Profile of circulating microRNAs in myalgic encephalomyelitis and their relation to symptom severity, and disease pathophysiology." Scientific reports 10.1 (2020): 1-13.

- Fu, Yong, Jiangning Chen, and Zhen Huang. "Recent progress in microRNA-based delivery systems for the treatment of human disease." ExRNA 1.1 (2019): 1-14.




DOI: http://dx.doi.org/10.52155/ijpsat.v30.2.4058

Refbacks

  • There are currently no refbacks.


Copyright (c) 2022 Maged Naser, Mohamed M. Naser, Lamia H. Shehata

Creative Commons License
This work is licensed under a Creative Commons Attribution 4.0 International License.